Over-Generous Taxpayers or Defective Calculators?

The Income Revenue Board (IRB) in Malaysia has announced that they have in excess of RM4 billion of tax revenue that shall be returned to 380,000 taxpayers this year.

The way the tax system works here for wage earners is that IRB automatically takes an estimated cut of their salaries every payday until the end of the financial year. After some serious number crunching and nipping a little interest from the coffers, IRB calculates the actual difference. Depending on the calculations, a taxpayer may have to give the difference to the authority or receive a refund around this time of the year.

Now, applying the classic principle of 90/10, this is how much an average taxpayer is getting back this year:

(0.1 * RM4,000,000,000) / (0.9 * 380,000) = RM1169.59

What do you know… I’m getting even less than the average!

Something must be wrong with their calculations. Perhaps they need the extra revenue for more accurate floating point calculators? ;)

Check out these links for some good reading, especially the Wikipedia one which has more links.

Links:

Too Much – A First-Ever Look at Wealth in the World
<URL:http://www.cipa-apex.org/toomuch/articlenew2006/Dec7a.html>

Wikipedia – Income disparity
<URL:http://en.wikipedia.org/wiki/Income_disparity>

Technorati Tags: , , , , , ,

Share

Google Finance Website Revamped

Google has changed its finance news and charting website, Google Finance.

Google Finance Screenshot

The new layout much cleaner and presentable as the page is divided into three columns. Recent quotes, stored using browser cookies, has been moved from the top right corner to the lower left corner. General news and corporate news of the recent quotes are featured in the center column. Most links on the page will bring you to a different page, except the top movers on the lower right.

However, the individual stock pages have not changed. :|

Overall looks pretty, but I have a few suggestions:

  • Dynamically refresh each section using individual settings (they do change now, which is really cool)
  • Display summary or beginning of news articles when mouseover links
  • Background colour-code recent quotes with their related news
  • Include stock historical prices and options

Maybe I should feedback these pointers to the Google Finance team? Although the traffic to this site is a fraction of that to Yahoo! Finance, I’m staying here because there are no fancy advertisements (full of offers that hardly benefit most of us but only the advertiser).

Technorati Tags: , , , , , , ,

Share

Cell Therapeutics to Submit New XYOTAX Drug Trial to FDA

Cell Therapeutics announced on Friday that it will close a XYOTAX drug trial, known as PIONEER, to submit a new trial protocol to the Food and Drug Administration (FDA). The new protocol will be known as PGT306 and will be submitted to the FDA by year’s end.

Because of the particularly low death rate among women patients during the trial, CTIC wants to focus its research on women with normal estogen levels. CEO Dr. James Bianco hopes that this group will be able to increase its uptake and metabolism of the chemotherapeutic drug because of estrogen.

Shares of CTIC dipped 2.2% to $1.86 on 8 December 2006.

Share chart of CTIC

Related posts:

Cell Therapeutics To Suspend Enrollment for PIONEER Drug Trial
<URL:http://glob.lokety.com/2006/11/cell-therapeutics-to-suspend.html>

Cell Therapeutics Signs Deal With Norvatis
<URL:http://glob.lokety.com/2006/09/cell-therapeutics-signs-deal-with.html>

Cell Therapeutics Up After Positive Xyotax Phase 1 Results
<URL:http://glob.lokety.com/2006/08/cell-therapeutics-up-after-positive.html>

Cell Therapeutics Signs Financing Agreement
<URL:http://glob.lokety.com/2006/06/cell-therapeutics-signs-financing.html>

Technorati Tags: , , , , , , ,

Share